Fidelity SPDR Advertisement
Home > Boards > US OTC > Medical - Drugs > Ocata Therapeutics Inc. (OCAT)

Advanced Cell Technology Shelves Myoblast Program...

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
ddls Member Profile
 
Followed By 21
Posts 8,339
Boards Moderated 0
Alias Born 06/18/09
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/25/2014 4:24:48 PM
Ocata Therapeutics to Present at 26th Annual Piper Jaffray Health Care Conference "Business Wire" - 11/25/2014 9:19:00 AM
Ocata Therapeutics Receives Advanced Therapy Medicinal Product Designation from the European Medicines Agency "Business Wire" - 11/24/2014 9:22:00 AM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 11/17/2014 6:01:13 AM
Advanced Cell Technology Changes Name to Ocata Therapeutics "Business Wire" - 11/14/2014 9:02:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/13/2014 4:16:33 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/10/2014 4:21:15 PM
Advanced Cell Technology to Host Conference Call and Webcast to Provide a Corporate Update for the Third Quarter of 2014 "Business Wire" - 11/7/2014 9:09:00 AM
Securities Registration Statement (simplified Form) (s-3/a) "Edgar (US Regulatory)" - 10/28/2014 4:06:17 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/20/2014 9:10:46 AM
Advanced Cell Technology Appoints LeRoux Jooste as SVP of Business Development & Chief Commercial Officer "Business Wire" - 10/20/2014 9:02:00 AM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 10/17/2014 4:07:47 PM
ACT Reports the Publication of Research on the Scalable Generation of Universal Platelets from Human Induced Pluripotent Stem... "Business Wire" - 10/17/2014 9:09:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/15/2014 6:02:59 AM
ACT Announces Positive Results from Two Clinical Trials Published in The Lancet Using Differentiated Stem Cell-Derived Retina... "Business Wire" - 10/14/2014 6:33:00 PM
Securities Registration Statement (simplified Form) (s-3) "Edgar (US Regulatory)" - 10/14/2014 5:08:34 PM
Securities Registration Statement (simplified Form) (s-3) "Edgar (US Regulatory)" - 10/14/2014 5:05:47 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/6/2014 6:01:21 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/1/2014 4:29:49 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/1/2014 4:29:25 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/1/2014 4:29:25 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/1/2014 4:29:01 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/1/2014 4:29:01 PM
Advanced Cell Technology Announces Final Patient Treated in Stargardt’s Macular Degeneration Phase 1 Trial in the United Ki... "Business Wire" - 9/25/2014 9:17:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/23/2014 4:06:32 PM
ddls   Monday, 02/24/14 10:11:36 AM
Re: crawford2012 post# 61362
Post # of 76858 
Advanced Cell Technology Shelves Myoblast Program...

"What most don't realize, is that they had a trial (Myoblast) that was approved for phase II trials back in 2008. The cost to start it up was estimated @ 15M, but instead of funding the heart trials, they wasted $$$ on expensive administration, and free stock handouts to themselves worth millions. Then they had the audacity to blame the government, religious groups, and eventually the investors for playing a role in their struggles.

They were also supposed to have had trials that were blood related (HG) since 2008, but that was all a farce as well and the company simply used this to hype up investors into thinking that big things were right around the corner. In reality, the only thing big in their plans was diluting shareholders with toxic financing and poor management decisions."


ACTC

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist